The Renasant Bio team (courtesy Renasant)
Kidney health biotech emerges with $54M to follow in Vertex’s footsteps
A Berkeley, CA-based biotech that wants to replicate Vertex’s success with corrector and potentiator medicines has raised a $54.5 million seed round.
The funding, disclosed …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
